Nicholas Investment Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
Nicholas Investment Partners's CELL Position: Q4 2021 in Review
Nicholas Investment Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 312,824 shares — an estimated $6.12M sold.
Nicholas Investment Partners first reported a position in CELL in Q3 2020 and held it in 5 quarters. The position peaked at $20.5M in Q2 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.
- Nicholas Investment Partners reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- Nicholas Investment Partners sold 312,824 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $6.12M.
- Nicholas Investment Partners first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 5 quarters.
- Nicholas Investment Partners's PhenomeX Inc. Common Stock position peaked at $20.5M in Q2 2021.
- 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.
Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.